Tear Film Innovations, Inc., a Carlsbad CA-based manufacturer of a device for the treatment of evaporative dry eye and related syndromes, completed an $8.5m Series B funding.
The round was led by Visionary Ventures Fund, L.P. and Bluestem Capital.
The company intends to use the funds to expand operations.
Led by Rob Thornhill, CEO, TFI manufactures the iLux system, a device for the treatment of evaporative dry eye and related syndromes including Meibomian Gland Dysfunction (MGD).
The iLux system, which received 510k clearance from the U.S. Food and Drug Administration in December 2017, enables eye care professionals to provide targeted therapy to blocked meibomian glands through an in-office treatment.